1. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia
   JUTTA RIES et al, 2013, Oncology Reports CrossRef
2. Difficulties in the Prognostic Study of Oral Leukoplakia: Standardisation Proposal of Follow-Up Parameters
   Cristina Saldivia-Siracusa et al, 2021, Frontiers in Oral Health CrossRef
3. Biomarkers of malignant transformation in oral leukoplakia: from bench to bedside
   Xinjia Cai et al, 2023, Journal of Zhejiang University-SCIENCE B CrossRef
4. Oral potentially malignant disorders: A scoping review of prognostic biomarkers
   Fernanda Weber Mello et al, 2020, Critical Reviews in Oncology/Hematology CrossRef
5. Carcinogenesis and Field Cancerization in Oral Squamous Cell Carcinoma
   Amritha Suresh et al, 2017, Contemporary Oral Oncology CrossRef
6. The Follow-Up Necessity in Human Papilloma Virus-Positive vs. Human Papilloma Virus-Negative Oral Mucosal Lesions: A Retrospective Study
   Armina Rushiti et al, 2023, Journal of Clinical Medicine CrossRef
7. Leptin receptor polymorphism Gln223Arg (rs1137101) in oral squamous cell carcinoma and potentially malignant oral lesions
   Patrícia Luciana Batista Domingos et al, 2014, SpringerPlus CrossRef
8. The expression of melanoma-associated antigen A (MAGE-A) in oral squamous cell carcinoma: an evaluation of the significance for tumor prognosis
   Anna Trippel et al, 2019, Oral and Maxillofacial Surgery CrossRef
9. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia and proliferative verrucous leukoplakia—A systematic review of retrospective studies
   Antonio Celentano et al, 2021, Oral Diseases CrossRef
10. Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer
    Stefan Hartmann et al, 2018, Journal of Cranio-Maxillofacial Surgery CrossRef
11. MAGE-A expression in oral and laryngeal leukoplakia predicts malignant transformation
    Christoph A. Baran et al, 2019, Modern Pathology CrossRef
12. Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy
    Roberto Rangel et al, 2022, Frontiers in Immunology CrossRef
13. The Immune Cells in the Development of Oral Squamous Cell Carcinoma
    Vito Carlo Alberto Caponio et al, 2023, Cancers CrossRef
14. MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiation
    Till Meyer et al, 2018, Molecular and Clinical Oncology CrossRef
15. Melanoma-associated antigen expression and the efficacy of tyrosine kinase inhibitors in head and neck cancer
    STEFAN HARTMANN et al, 2015, Oncology Letters CrossRef
16. Clinical significance of head and neck squamous cell cancer biomarkers
    Hana Polanska et al, 2014, Oral Oncology CrossRef
17. Malignant transformation of oral leukoplakia is associated with macrophage polarization
    Manuel Weber et al, 2020, Journal of Translational Medicine CrossRef
18. Importance of the PD-1/PD-L1 Axis for Malignant Transformation and Risk Assessment of Oral Leukoplakia
    Jutta Ries et al, 2021, Biomedicines CrossRef
19. MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer
    Stefan Hartmann et al, 2018, Clinical Oral Investigations CrossRef